US Patent Issued to Wake Forest University Health Sciences on June 30 for "SIRP-gamma targeted agents for use in the treatment of cancer" (Chinese, American Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,628, issued on June 30, was assigned to Wake Forest University Health Sciences (Winston-Salem, N.C.).

"SIRP-gamma targeted agents for use in the treatment of cancer" was invented by Hui-Kuan Lin (Winston-Salem, N.C.), Chuan Xu (Chengdu, China), Xiu-Wu Bian (Chongqing, China), Sarah Haigh Molina (Winston-Salem, N.C.) and Mark Furth (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods relating to SIRPgamma as a biomarker for cancer cells, and in particular of cancer stem cells and lung adenocarcinoma. Disclosed are also methods of treatment, which involve administering a SIRPgamma targeted agent to a subject with canc...